3 results
Approved WMOCompleted
To determine the within and between variability of pharmacokinetic (PK) profiles in patients treated with DOACs in daily practice
Approved WMOCompleted
Primary:Subjects with salvageable giant cell rich tumors:- To evaluate subjects who do not require surgery during the study- To evaluate subjects who are able to undergo a less morbid surgical procedure compared with the planned surgical procedure…
Approved WMOCompleted
To measure DOAC levels just before surgery of all DOAC patients in the LUMC with elective surgery for which ceasing of DOAC treatment is required.